Category: Press Releases

Arlington, VA & Reykjavik, Iceland — May 23, 2025 — Kerecis, the company pioneering the use of sustainably sourced fish skin in cellular therapy and tissue regeneration, today announced that…

Arlington, Va. and Reykjavik, Iceland – April 14, 2025 – Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue regeneration,…

ARLINGTON, VA and REYKJAVIK, Iceland – December 27, 2024 Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue regeneration and protection,…

Munich, Germany & Reykjavik, Iceland – December 10, 2024 – Kerecis, the pioneer in the use of fish skin and fatty acids for tissue regeneration and protection, announces the designation…

LAS VEGAS–(BUSINESS WIRE)–Kerecis, the pioneer in the use of fish-skin and fatty acids for tissue regeneration and protection, is a high-profile participant and presenter at this year’s Symposium on Advanced…

60% of the Medicare population now has access to Kerecis Shield in private doctors’ clinics Kerecis, the company pioneering the use of sustainably sourced fish-skin and fatty acids in cellular…

Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue regeneration and protection, today announced the availability of Shield Spiral, an…

A panel of female medical professionals will discuss the clinical evidence of Kerecis’ products in surgical and outpatient settings. Kerecis, the pioneer in the use of fish skin and fatty…

  Arlington, VA and Reykjavik, Iceland – May 1, 2024 – Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue…

Kerecis has been nominated as a finalist for the prestigious Life Sciences Company of the Year at the 2024 ICON Awards, presented by the Maryland Tech Council (MTC). This annual…

Product combines fish-skin grafts and silicone for optimal wound healing environment. Kerecis, the company pioneering the use of sustainably sourced fish skin and fatty acids in cellular therapy and tissue…

Consensus symposium and multiple poster abstracts demonstrate efficacy of fish-skin grafts in wound treatment and reconstructive surgery  Kerecis today announced the publication of a multi-disciplinary clinical consensus about the utilization of…

More than 40% of the Medicare population now enjoys coverage for Kerecis Shield. Multiple Medicare Administrative Contractors (MACs) have approved coverage for Kerecis Shield. The product integrates the Kerecis medical-fish-skin…

Arlington, VA and Reykjavik, Iceland—August 14, 2023—Kerecis®, the company pioneering the use of fish-skin and fatty acids for tissue regeneration and protection, is donating its GraftGuide® fish-skin burn product for…